Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Geninus Logo
Geninus Growth Score
83
CB Rank
45278
Heat Score
80
Geninus is a biotechnology company that provides clinical genome analysis solutions for precision medicine clinics.
Founded
obfuscation
PublicPost-IPO Debt Seoul, Seoul-t'ukpyolsi, South Korea51-100 www.kr-geninus.com
Analytics
Biotechnology
Precision Medicine
Overview

Geninus
Total Funding
obfuscation
Growth Score
83
Heat Score
80

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score83
-3 pts
in past quarter
Heat Score 80
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Geninus

CB Rank
45278
Geninus is a biotechnology company that provides clinical genome analysis solutions for precision medicine clinics.
Founded
obfuscation
PublicPost-IPO Debt Seoul, Seoul-t'ukpyolsi, South Korea51-100 www.kr-geninus.com
Analytics
Biotechnology
Precision Medicine

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Geninus Inc.
Also Known As 지니너스
Operating Status Active
Stock Symbol  KOSDAQ:389030
Company Type For Profit
About the Company

Geninus is a precision genomics and bioinformatics company. It focuses on genomic analysis, spatial multi-omics, AI-driven biomarker discovery, digital pathology, and companion diagnostics for oncology and precision medicine. The company's analysis platform provides visualization and analysis tools for spatial biology and transcriptomics

datasets.

Phone Number +82 02 6949 6570
Contact Email insideme.geninus@gmail.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Space Insight
A software tool that maps the distribution and state of immune cells within tumors to support drug development, especially for antibody-drug conjugates (ADC).
MEDINSIGHT
An AI-powered digital pathology solution for clinical genomics and precision medicine applications.

Research & Development

Geninus is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
2
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
KB Investment Logo
KB Investment
—
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
—
KB Investment Logo
KB Investment
—
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
—
KB Investment Logo
KB Investment
—
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
—
KB Investment Logo
KB Investment
—
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
—
KB Investment Logo
KB Investment
—
Post-IPO Debt - Geninus Logo
Post-IPO Debt - Geninus
—
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1

Employee Profiles

News

News and Press

News•Apr 21, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 13, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

470
-2.08%
 in past month

Active Website Tech Count

56Geninus is actively using 56 technologies for its website, according to BuiltWith. These include SPF, Common Crawl, and  Apple Mobile Web Clips Icon.

Total IP

2Geninus has registered 2 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Geninus's headquarters? Geninus is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who invested in Geninus? Geninus has 9 investors including KB Investment and  Company K Partners.When was the last funding round for Geninus? Geninus closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Geninus's competitors? Alternatives and possible competitors to Geninus may include Tempus, SOPHiA GENETICS, and  Caris Life Sciences.How much funding has Geninus raised to date? Geninus has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|